Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Language
Publication year range
1.
Genet Mol Res ; 14(2): 5577-84, 2015 May 25.
Article in English | MEDLINE | ID: mdl-26125755

ABSTRACT

We examined the variation in plasma levels of endothelin (ET), calcitonin gene-related peptide (CGRP), nitric oxide (NO), and malondialdehyde (MDA), as well as superoxide dismutase (SOD) activity, in acute myocardial ischemia reperfusion injury in a rabbit model. Seventy rabbits were randomly assigned into 3 groups. Open-chest surgery (OCS) was performed for all rabbits. Group A (N = 20) received sham-surgery, group B (N = 25) was the reperfusion group, and group C (N = 25) was the infarction group. At 12 h after chest clo-sure, plasma ET levels in groups B and C were clearly increased, while CGRP levels were clearly decreased, particularly in group B. At 24 h after chest closure, ET levels were higher than before OCS, while there was no significant difference between groups B and C. ET in group B was decreased, while that in group C was increased at 12 h. No significant difference in CGRP was observed between 12 and 24 h after chest closure. NO levels in groups B and C at 12 h after chest closure were significantly decreased compared to those before OCS. NO levels in group B at 24, 48, and 72 h were significantly lower than those at 12 h, while those of group C were not significantly changed after 12 h. Dynamic monitoring and comparison of plasma levels of ET, CGRP, NO, and MDA as well as SOD activity revealed that appropriate intervention of these factors may reduce reperfusion injury.


Subject(s)
Calcitonin Gene-Related Peptide/blood , Endothelins/blood , Malondialdehyde/blood , Myocardial Reperfusion Injury/blood , Nitric Oxide/blood , Animals , Disease Models, Animal , Humans , Myocardial Reperfusion Injury/pathology , Myocardium/pathology , Rabbits , Superoxide Dismutase/blood
2.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;47(7): 540-547, 07/2014. tab, graf
Article in English | LILACS | ID: lil-712968

ABSTRACT

Intercellular adhesion molecule-1 (ICAM-1) is an important factor in the progression of inflammatory responses in vivo. To develop a new anti-inflammatory drug to block the biological activity of ICAM-1, we produced a monoclonal antibody (Ka=4.19×10−8 M) against human ICAM-1. The anti-ICAM-1 single-chain variable antibody fragment (scFv) was expressed at a high level as inclusion bodies in Escherichia coli. We refolded the scFv (Ka=2.35×10−7 M) by ion-exchange chromatography, dialysis, and dilution. The results showed that column chromatography refolding by high-performance Q Sepharose had remarkable advantages over conventional dilution and dialysis methods. Furthermore, the anti-ICAM-1 scFv yield of about 60 mg/L was higher with this method. The purity of the final product was greater than 90%, as shown by denaturing gel electrophoresis. Enzyme-linked immunosorbent assay, cell culture, and animal experiments were used to assess the immunological properties and biological activities of the renatured scFv.


Subject(s)
Animals , Female , Humans , Male , Mice , Gene Expression/physiology , Immunoglobulin Fragments/biosynthesis , Intercellular Adhesion Molecule-1/immunology , Protein Refolding , Protein Renaturation , Single-Chain Antibodies/biosynthesis , Antigen-Antibody Complex , Anti-Inflammatory Agents/pharmacology , Antibodies, Monoclonal/biosynthesis , Cell Adhesion , Chromatography , Dialysis , Enzyme-Linked Immunosorbent Assay , Ear Auricle/drug effects , Escherichia coli/genetics , Genetic Vectors , Immunoglobulin Fragments/pharmacology , Inclusion Bodies/metabolism , Intercellular Adhesion Molecule-1/drug effects , Leukocytes, Mononuclear/metabolism , Plasmids , Protein Engineering/methods , Single-Chain Antibodies/pharmacology , Xylenes/pharmacology
3.
Braz J Med Biol Res ; 47(7): 540-7, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24919171

ABSTRACT

Intercellular adhesion molecule-1 (ICAM-1) is an important factor in the progression of inflammatory responses in vivo. To develop a new anti-inflammatory drug to block the biological activity of ICAM-1, we produced a monoclonal antibody (Ka=4.19 × 10(-8) M) against human ICAM-1. The anti-ICAM-1 single-chain variable antibody fragment (scFv) was expressed at a high level as inclusion bodies in Escherichia coli. We refolded the scFv (Ka=2.35 × 10(-7) M) by ion-exchange chromatography, dialysis, and dilution. The results showed that column chromatography refolding by high-performance Q Sepharose had remarkable advantages over conventional dilution and dialysis methods. Furthermore, the anti-ICAM-1 scFv yield of about 60 mg/L was higher with this method. The purity of the final product was greater than 90%, as shown by denaturing gel electrophoresis. Enzyme-linked immunosorbent assay, cell culture, and animal experiments were used to assess the immunological properties and biological activities of the renatured scFv.


Subject(s)
Gene Expression/physiology , Immunoglobulin Fragments/biosynthesis , Intercellular Adhesion Molecule-1/immunology , Protein Refolding , Protein Renaturation , Single-Chain Antibodies/biosynthesis , Animals , Anti-Inflammatory Agents/pharmacology , Antibodies, Monoclonal/biosynthesis , Antigen-Antibody Complex , Cell Adhesion , Chromatography , Dialysis , Ear Auricle/drug effects , Enzyme-Linked Immunosorbent Assay , Escherichia coli/genetics , Female , Genetic Vectors , Humans , Immunoglobulin Fragments/pharmacology , Inclusion Bodies/metabolism , Intercellular Adhesion Molecule-1/drug effects , Leukocytes, Mononuclear/metabolism , Male , Mice , Plasmids , Protein Engineering/methods , Single-Chain Antibodies/pharmacology , Xylenes/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL